We are recruiting a postdoctoral researcher to work on a collaborative programme, funded by Eli-Lilly for examining strategies to promote remyelination, and protect against neurodegeneration in mouse models relevant to progressive multiple sclerosis. The research programme will use focal toxin induced demyelinating lesions in the cerebellar circuit, pharmacology with long acting agonists supplied by Eli Lilly, in vivo recordings of neuronal activity, quantitative histology and imaging, ultrastructural and functional measures of remyelination, and mechanistic profiling including single nucleus transcriptomics. We are looking for a dedicated postdoctoral researcher to join this exciting collaboration.
Successful applicants should have a PhD in the field of neuroscience, neuroimmunology, glial biology or neurometabolism or similar, or be close to the completion of their degree. A strong background in vivo animal work, stereotaxic surgery, and imaging is essential for this position. Expertise in vivo recordings and advanced brain-imaging methods would be an advantage. It is essential that the post-holder is organised, able to work collaboratively as a member of a team and can communicate effectively and clearly.
United Kingdom Academic Biology Biomedical and Physiology On-site Postdoc University of Cambridge